Celladon Corporation Receives Notice of Allowance by U.S. Patent and Trademark Office for Broad Patent Covering Lead Drug Candidate MYDICAR(R)

Tuesday, March 23, 2010 General News
Email Print This Page Comment
Font : A-A+

Patent to Cover Use of All Adeno-Associated Viral Vectors and Routes of Administration for Delivery of SERCA2a Gene for Treatment of Heart Failure

Contacts:

David Schull or Martina Schwarzkopf, Ph.D.

Russo Partners

212-845-4271

212-845-4292

david.schull@russopartnersllc.com

martina.schwarzkopf@russopartnersllc.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook